Close Menu

NEW YORK – As the COVID-19 pandemic continues to stress healthcare systems across the US and world, clinical labs and diagnostic firms have raced to ramp up SARS-CoV-2 test volumes.

But while demand for SARS-CoV-2 has soared, volume for non-COVID-19 testing has plummeted as patients are putting off elective procedures and routine doctor's visits.

This week, Quest Diagnostics filed a form 8-K in which it noted that during the last two weeks of March the company's test volumes, inclusive of COVID-19 tests, declined by more than 40 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.